New Launch5 Dec 2025, 11:32 am
Anuh Pharma Granted CEP from EDQM for Sulfadimethoxine
AI Summary
Anuh Pharma Limited has announced that it has been granted the Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for Sulfadimethoxine. This approval underscores Anuh Pharma’s commitment to delivering high-quality Active Pharmaceutical Ingredients that meet the most stringent global regulatory standards. The CEP for Sulfadimethoxine will expand access to regulated markets, providing enhanced reliability, compliance, and supply security for customers.
Key Highlights
- Anuh Pharma granted CEP from EDQM for Sulfadimethoxine
- Reinforces commitment to delivering high-quality Active Pharmaceutical Ingredients
- Expanded access to regulated markets
- Enhanced reliability, compliance, and supply security for customers
- New product launch of Sulfadimethoxine